Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECT
NCT02462590Phase 4Completed
- Sponsor
- McMaster University
- Start
- Jun 2015
- Primary completion
- Mar 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 3
01
Overview
A Phase 4 trial of Lactobacillus rhamnosus GG in ventilator-associated pneumonia (VAP), Clostridioides difficile infection (CDI), antibiotic-associated diarrhea (AAD), sponsored by McMaster University. Started Jun 2015; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
ventilator-associated pneumonia (VAP)Clostridioides difficile infection (CDI)antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT02462590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462590.